Sanofi Consumer Healthcare said its growth was driven by successful product launches and the successful relaunch of two ...

Sanofi Consumer Healthcare India surged 12.56% to Rs 5385 after the company announced strong financial results for the second quarter of 2025.

Aurobindo Pharma's Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA), margins and net profit was also ...

Building on bispecific antibodies, four of which have been approved by the FDA to treat relapsed/refractory multiple myeloma, ...

Company shares partnership and clinical updates including $7 million Sanofi milestone and more information on patient ...

Resting-state EEG (RS-EEG) has emerged as a non-invasive, low-cost tool for Alzheimer’s disease (AD) diagnosis and ...

Converging evidence supports a key pathogenic role of the glymphatic system in the accumulation of pathological aggregates in ...

BioMarin Pharmaceutical BMRN reported second-quarter 2025 adjusted earnings per share (EPS) of $1.44, which beat the Zacks ...

During a live event, Hans Lee, MD, and participants discussed potential approaches to modifying frontline multiple myeloma ...

Newgen Software Technologies Ltd, Godfrey Phillips India Ltd, Sanofi Consumer Healthcare India Ltd and New India Assurance ...

The UK’s National Health Service (NHS) and local authorities have started the rollout of world-first gonorrhoea vaccination ...